Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism

Diabetologia

Volumn 50, Issue 9, 2007, Pages 1960-1968

  Han, R ^a   Lai, R ^b   Ding, Q ^a   Wang, Z ^a   Luo, X ^a   Zhang, Y ^a   Cui, G ^a   He, J ^a   Liu, W ^a   Chen, Y ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

AMP activated protein kinase; AMPK; APOA I; Apolipoprotein A I; Endocytosis; Fat mass; Glucose homeostasis; Insulin resistance; Type 2 diabetes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; APOLIPOPROTEIN A1; CLATHRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FAT CONTENT; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; KNOCKOUT MOUSE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ANIMALS; APOLIPOPROTEIN A-I; CELL LINE; DEOXYGLUCOSE; ENZYME ACTIVATION; GLUCOSE; MICE; MULTIENZYME COMPLEXES; MUSCLE CELLS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 34547696757     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0752-7     Document Type: Article

References (30)

1. Assmann G, Nofer JR (2003) Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54:321-341
2. Linsel-Nitschke P, Tall AR (2005) HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 4:193-205
3. Oram JF, Heinecke JW (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85:1343-1372
4. Silver DL, Tall AR (2001) The cellular biology of scavenger receptor class B type I. Curr Opin Lipidol 12:497-504
5. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA (2004) High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 101:6999-7004
6. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
7. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415-1428
8. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448-1454
9. Mooradian AD, Haas MJ, Wong NC (2004) Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes 53:513-520
10. Frenais R, Ouguerram K, Maugeais C et al (1997) High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia 40:578-583
11. Murao K, Wada Y, Nakamura T, Taylor AH, Mooradian AD, Wong NC (1998) Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J Biol Chem 273:18959-18965
12. Morcillo S, Cardona F, Rojo-Martinez G et al (2005) Association between MspI polymorphism of the APO AI gene and type 2 diabetes mellitus. Diabet Med 22:782-788
13. Klip A, Guma A, Ramlal T, Bilan PJ, Lam L, Leiter LA (1992) Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 130:2535-2544
14. Williamson R, Lee D, Hagaman J, Maeda N (1992) Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad Sci USA 89:7134-7138
15. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439-451
16. Le PU, Benlimame N, Lagana A, Raz A, Nabi IR (2000) Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility. J Cell Sci 113:3227-3240
17. Yamauchi T, Kamon J, Minokoshi Y et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
18. Tomas E, Tsao TS, Saha AK et al (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99:16309-16313
19. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ (2003) Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52:1355-1363
20. Larkin JM, Brown MS, Goldstein JL, Anderson RG (1983) Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts. Cell 33:273-285
21. Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25
22. Carling D (2004) The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 29:18-24
23. Musi N (2006) AMP-activated protein kinase and type 2 diabetes. Curr Med Chem 13:583-589
24. Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C (2000) 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49:896-903
25. Brunham LR, Kruit JK, Pape TD et al (2007) Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 13:340-347
26. de Beer MC, Castellani LW, Cai L, Stromberg AJ, de Beer FC, van der Westhuyzen DR (2004) ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36. J Lipid Res 45:706-715
27. Castellani LW, Goto AM, Lusis AJ (2001) Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes 50:643-651
28. Eckhardt ER, Cai L, Sun B, Webb NR, van der Westhuyzen DR (2004) High density lipoprotein uptake by scavenger receptor SR-BII. J Biol Chem 279:14372-14381
29. Martinez LO, Jacquet S, Esteve JP et al (2003) Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 421:75-79
30. Kozyraki R, Fyfe J, Kristiansen M et al (1999) The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat Med 5:656-661